Open navigation
Search
Search

Select your region

Life Sciences & Healthcare

Think globally, act locally

Latest

  • Can Switzerland protect patient access to innovative medicines in era of most-favoured-nation pricing?
    20 Feb 2026 13 min read
  • Transposition Time Updates – Nordic Trio: Denmark, Finland, and Sweden Progress Towards New EU Product Liability Directive Implementation
    12 Feb 2026 6 min read
  • Medical technologies in defence and aerospace: Key themes and emerging questions in regulation
    09 Jan 2026 7 min read
  • Positive and negative pointers in clinical trial prior art: diverging inventive step outcomes at the EPO and UPC
    08 Jan 2026 13 min read

Rising regulatory requirements, increasing price and cost pressures, and new technological advancements pose major challenges for companies operating in the life sciences and health care sectors. To succeed in this dynamic and rapidly changing environment, companies need a partner with a global perspective who is thoroughly versed in the local market environment. CMS is just that partner for you.

A Global Perspective.

The CMS Life Sciences and Healthcare Sector Group consists of over 480 lawyers across Europe. Our multidisciplinary team advises you on every aspect along the business cycle of a product or service. We assist you with company formation, financing or finding business partners, protecting innovations as well as implementing your business strategy in Switzerland or adapting to the regulatory environment of the Swiss healthcare market. Our market knowledge and multidisciplinary advice is appreciated by world-renowned manufacturers of pharmaceuticals or medical devices as well as by young start-up companies or domestic service providers, such as hospitals, pharmacy groups or doctors with their own practice.

We have a long standing experience in supporting our Life Sciences and Healthcare clients in:

  • Research and development (particularly in clinical trials)
  • Patent enforcement
  • Regulatory authorisations
  • Advertising and distribution issues
  • Pricing strategies and reimbursements under social security law
  • Compliance
  • Liability issues
  • Data protection

We provide truly full service.

When Experience Matters.

Whether it is the launch of a new therapy, an adaptation to regulatory requirements in Switzerland, an international patent dispute, the formation of a strategic alliance or a merger with a competitor, we know your market environment and understand how we can support you in taking the next steps. Together with you, we ask the right questions and find creative solutions. In doing so, we anticipate risks and solve problems before they arise. We advise you on your contracts or defend your interests before civil and administrative courts. Whatever challenges you face, wherever the problem lies: The CMS team has exactly the right solution for you!

Our clients include:

  • Bayer
  • Vista Klinik
  • Mobile Health
  • Pfizer
  • GE Healthcare
  • Takeda
  • Eli Lilly
  • Zur Rose 

Recent highlights of our work:

  • Representing Bayer (Switzerland), the Swiss branch of the leading Germany-based global pharmaceuticals manufacturer.  Our Switzerland-based competition/antitrust team is advising Bayer in the highly-contested Swiss administrative proceedings regarding price recommendations for medication against erectile dysfunction traded over-the-counter. 
  • Advising mobile Health AG in connection with Consilium Care™, an electronic Patient Reported Outcomes (ePRO) SaaS system which includes the CE-marked MDD Class I medical device, Pro Care. Pro Care improves the symptoms progression monitoring for cancer patients, as well as the monitoring of their wellbeing (based on the ECOG scale).
  • Supporting Vista Klinik on building its acquisition portfolio of clinics across Switzeralnd.
  • Representation of marketing authorization holders in appeal proceedings before the Federal Supreme Court and the Federal Administrative Court concerning the inclusion of medicinal products in the list of specialities and the triennial price review by the Federal Office of Public Health (FOPH) .
  • Representation of manufacturers of inhalation devices in appeal proceedings before the Federal Administrative Court concerning adjustment of the list of medicinal products and medical devices (MiGeL).
  • Representation of medical suppliers in cantonal administrative proceedings concerning cooperation with physicians for undue benefits.
  • Representing and advising hospital managers in criminal proceedings concerning the handling of medical devices.

Find an expert

Awards & Recognitions
01
  • Quote
    'Due to very good networking', CMS 'can provide know-how in a variety of matters', especially at a multi-jurisdictional level. Regulatory, compliance, financial benefits and pricing advice, as well as the negotiation of agreements and representation in court form the main areas of expertise.
    The Legal 500, Healthcare and life sciences, Switzerland, 2019

Life Sciences & Healthcare Insights

CMS Expert Guide to advertising of medicines and medical devices

26 Mar 2026 2 min read

Can Switzerland protect patient access to innovative medicines in era of most-favoured-nation pricing?

20 Feb 2026 13 min read

Transposition Time Updates – Nordic Trio: Denmark, Finland, and Sweden Progress Towards New EU Product Liability Directive Implementation

12 Feb 2026 6 min read

Medical technologies in defence and aerospace: Key themes and emerging questions in regulation

09 Jan 2026 7 min read

Positive and negative pointers in clinical trial prior art: diverging inventive step outcomes at the EPO and UPC

08 Jan 2026 13 min read

Digital health apps and telemedicine: Updated CMS Expert Guide for 30 jurisdictions

01 Dec 2025 2 min read

Transposition Time – Update on the EU Member States’ adoption of the new Product Liability Directive

17 Nov 2025 6 min read

Die Schweiz wird zum Referenzland für amerikanische Medikamentenpreise: Was sind die Auswirkungen für die Schweiz?

13 Nov 2025 6 min read

Events

  • Switzerland
    08 Apr 2026

    CMS at Fordham IP & Policy Conference

  • Switzerland
    21 Apr 2026

    On the Pulse webinar series 2026 - Spring/Summer

  • Switzerland
    28 Apr 2026

    IP Insights webinar series 2026

  • Switzerland
    02 May 2026

    CMS at INTA 2026

  • Switzerland
    12 May 2026

    "Anti Post Moot Blues"-Event 2026

Back to top Back to top
Warning: Fraudulent emails and messages